Find, compare & contact
Icatibant
API Manufacturers & Suppliers
Filters
Reset current filters
Type
Production region
Qualifications
Country of origin
Follow us
Distributor
Produced in:
Established in: 1987
MOQ: 10 g
Employees: 50+
ISO 9001:2015 & SGS audited supplier
One-stop CDMO Solutions for APl and Key intermediates
Specialized in APIs & Pharmaceutical Intermediates for 37 years
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
Produced in:
Established in: 1984
MOQ: -
Employees: 21,650
Diverse portfolio of 180+APIs
1754+ DMF across global markets
1100+ patents filed, and more than 70 own patents granted
+ 0
All certificates
Producer
Produced in:
Established in: 1944
MOQ: -
Employees: 4,000
14 international API plant sites
Portfolio of 350+ APIs
Teva is among the world’s largest generic drug/API manufacturers
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Icatibant API 130308-48-4?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Icatibant. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Icatibant
- Cas Number:
- 130308-48-4
- DrugBank number:
- DB06196
- Unique Ingredient Identifier:
- 7PG89G35Q7
About Icatibant
Some technical information about this product: Icatibant (Firazyr) is a synthetic peptidomimetic drug consisting of ten amino acids, and acts as an effective and specific antagonist of bradykinin B2 receptors. It has been approved in the EU for use in hereditary angioedema, and is under investigation for a number of other conditions in which bradykinin is thought to play a significant role. Icatibant currently has orphan drug status in the United States and FDA approved on August 25, 2011.
Check who is selling Icatibant in the overview above.
Icatibant is a type of Indifferent resources
Indifferent resources, in the context of pharmaceutical active pharmaceutical ingredients (APIs), refer to the subcategory of materials used in the manufacturing process that do not react with or significantly affect the chemical properties of the API. These resources play a crucial role in ensuring the purity and stability of the final pharmaceutical product.
Indifferent resources include solvents, excipients, catalysts, and other auxiliary substances used during API synthesis or formulation. They are carefully selected to have minimal reactivity with the API, preserving its chemical integrity and therapeutic efficacy. The choice of indifferent resources depends on factors such as the API's chemical structure, solubility, and stability requirements.
By employing indifferent resources, pharmaceutical manufacturers can mitigate the risk of unwanted chemical reactions or degradation during the production and storage of APIs. This, in turn, enhances the quality and reliability of the pharmaceutical product.
In the pharmaceutical industry, the selection and use of indifferent resources are critical in complying with regulatory guidelines and ensuring the safety and efficacy of medications. Manufacturers must adhere to Good Manufacturing Practices (GMP) and perform comprehensive compatibility studies to identify suitable indifferent resources for their specific APIs.
Overall, indifferent resources serve as indispensable components in the pharmaceutical API manufacturing process, guaranteeing the production of high-quality, stable, and safe medications that meet stringent regulatory standards.
Icatibant (Indifferent resources), classified under Others
The others category refers to pharmaceutical APIs that do not fall under specific classifications such as antibiotics, antivirals, analgesics, or cardiovascular drugs. These APIs are diverse in nature and serve various therapeutic purposes, making them a crucial component of pharmaceutical formulations.
Pharmaceutical companies develop APIs in the others category to address specific medical conditions or target novel biological pathways. This category includes APIs used in oncology, neurology, immunology, and other specialized areas of medicine. The APIs in this category are often designed to interact with specific molecular targets or receptors, providing targeted therapeutic effects.
The development of APIs in the others category requires extensive research and testing to ensure their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers employ advanced techniques such as chemical synthesis, biotechnology, and genetic engineering to produce these APIs.
Due to the broad range of applications and therapeutic uses, APIs in the others category contribute significantly to the advancement of medical treatments. Pharmaceutical companies constantly strive to innovate and discover new APIs within this category to address unmet medical needs and improve patient outcomes.
In conclusion, the others category of pharmaceutical APIs encompasses a diverse range of active ingredients used in drug formulation. These APIs play a crucial role in developing innovative therapies across various therapeutic areas, contributing to advancements in healthcare and patient well-being.
Icatibant manufacturers | traders | suppliers
We have 12 companies offering Icatibant produced in 4 different countries.
Get in contact with the supplier of your choice:
- Sinoway industrial Co.,Ltd from China, product country of origin China
- USV from India, product country of origin India
- Jiangsu Hansoh Pharma from China, product country of origin China
- BCN Peptides from Spain, product country of origin Spain
- AMBIOPHARM from United States, product country of origin Unknown
- Dr. Reddy's from India, product country of origin India
- Teva API from Israel, product country of origin Unknown
- MSN Life Sciences from India, product country of origin India
- Cipla from India, product country of origin India
- Biophore India from India, product country of origin India
- Sun Pharma from India, product country of origin India
- Mylan from India, product country of origin India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
